Small Molecules
26 May 2020
DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH26 May 2020
Qurient Announces U.S. FDA Clearance of IND Application for Q702, a Novel Cancer ImmunotherapyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports